Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(3S)-3-methyl-D-aspartic acid is a synthetic derivative of the amino acid D-aspartic acid. It is a small molecule with the chemical formula C5H9NO4 and a molecular weight of 147.13 g/mol[7][10]. While D-aspartic acid itself is naturally occurring in the human body and has been studied for its roles in neuroendocrine regulation and reproductive function, (3S)-3-methyl-D-aspartic acid represents a methylated analog that may be used experimentally to probe structure-activity relationships at glutamate receptors or other amino-acid sensitive targets. There are no approved medical indications or marketed products containing this compound; it remains an investigational molecule primarily referenced in research contexts[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (3S)-3-methyl-D-aspartic acid.